Acticor Makes Case For First-In-Class Heart Drug Glencozimab

French Biotech Initiates Phase II/III Trials

 
• By Kevin Grogan
  
Human heart with blood vessels
• Source: Shutterstock

More from Cardiovascular

More from Therapy Areas